Research Article
Construction and Comprehensive Analyses of a Competing Endogenous RNA Network in Tumor-Node-Metastasis Stage I Hepatocellular Carcinoma
Table 1
Clinical characteristics of the included patients.
| Characteristics | Number of sample size, n = 171 (%) (mRNA, lncRNA) | Number of sample size, n = 172 (%) (miRNA) |
| Age (years) | ≥60 | 95 (55.56) | 95 (55.23) | <60 | 76 (44.44) | 77 (44.77) |
| Gender | Female | 50 (29.24) | 49 (28.49) | Male | 121 (70.76) | 123 (71.51) |
| Family history | Yes | 52 (30.41) | 51 (29.65) | No | 119 (69.59) | 121 (70.35) |
| Race | White | 78 (45.61) | 77 (44.77) | Asian | 81 (47.37) | 81 (47.09) | Black or african american | 8 (4.68) | 8 (4.65) | NA | 4 (2.34) | 6 (3.49) |
| Tumor status | With tumor | 44 (25.73) | 46 (26.74) | Tumor free | 117 (68.42) | 116 (67.44) | NA | 10 (5.85) | 10 (5.81) |
| Hepatitis B virus infection | | | Yes | 69 (40.35) | 70 (40.70) | No | 96 (56.14) | 96 (55.81) | NA | 6 (3.51) | 6 (3.49) |
| Histologic grade | Grade 1 | 25 (14.62) | 25 (14.53) | Grade 2 | 80 (46.78) | 80 (46.51) | Grade 3 | 55 (32.16) | 56 (32.56) | Grade 4 | 10 (5.85) | 11 (6.40) | NA | 1 (0.58) | 0 (0.00) |
| Vascular invasion | Macro | 5 (2.92) | 5 (2.91) | Micro | 17 (9.94) | 18 (10.47) | None | 137 (80.12) | 138 (80.23) | NA | 12 (7.02) | 11 (6.40) |
| Residual tumor | R0 | 154 (90.06) | 155 (90.12) | R1 | 5 (2.92) | 5 (2.91) | R2 | 0 (0.00) | 0 (0.00) | RX | 9 (5.26) | 9 (5.23) | NA | 3 (1.75) | 3 (1.74) |
| Vital status | Living | 129 (75.44) | 131 (76.16) | Deceased | 42 (24.56) | 41 (23.84) |
| Relapse | Yes | 62 (36.26) | 65 (37.79) | No | 88 (51.46) | 88 (51.16) | NA | 21 (12.28) | 19 (11.05) |
|
|